Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER).

Trial Profile

Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER).

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2014

At a glance

  • Drugs Pitavastatin (Primary) ; Bezafibrate
  • Indications Atherosclerosis; Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms PIONEER
  • Most Recent Events

    • 20 Nov 2013 Status changed from active, no longer recruiting to completed.
    • 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 18 Nov 2013 Primary endpoint 'Intima-media-thickness' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top